DORNASE ALFA
dornase alfa 2.5 mg/2.5 mL inhalation solution, 30 x 2.5 mL ampoules
DORNASE ALFA (6120D)
6120D
Manner of administration:Inhalation
Restriction 9624
Indication: Cystic fibrosis
Restriction 9591
Indication: Cystic fibrosis
Restriction 9592
Indication: Cystic fibrosis
Treatment phase: Continuing treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 2 | Max qty units: 60 | # of repeats: 5 | DPMQ: $1,539.86 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Pulmozyme | |||||
